National Academies Press: OpenBook
« Previous: Emerging Infections as a Cause of Concern
Suggested Citation:"Emerging Diseases in Mice and Rats." National Research Council. 2000. Microbial Status and Genetic Evaluation of Mice and Rats: Proceedings of the 1999 US/Japan Conference. Washington, DC: The National Academies Press. doi: 10.17226/9987.
×

Emerging Diseases in Mice and Rats

Toshio Itoh

Deputy Director, ICLAS Monitoring Center

Central Institute for Experimental Animals, Kawasaki, Japan

The two topics of my discussion are examples. The first topic is an example of contamination of a human tumor line passaged in immunodeficient mice, which illustrates the effects of Helicobacter hepaticus infection on animal experiments. The second topic is not actually related to H. hepaticus infection, but I use this organism to illustrate a method for establishing test items when a new infection appears in laboratory animals.

H. HEPATICUS CONTAMINATION OF HUMAN TUMOR TISSUES PASSAGED IN IMMUNODIFICIENT MICE

One aspect of cancer research at the Central Institute for Experimental Animals involves the collection of tumor tissues from patients and the subcutaneous inoculation into immunodeficient animals such as nude mice or mice with severe combined immunodeficiency (SCID) mice. In this process of passaging human tumor tissues using immunodeficient mice, focal necrosis appears very often in the liver of the cancer-bearing mice after a certain period. I describe below the characteristics of the infected mice, the process of the infection, and the countermeasures against it.

Although bacteriologic and histopathologic tests were performed using mice with liver lesions, and serum antibody tests were performed using sentinel mice to detect known pathogens, the cause of the lesions was not clear at the start of testing. After H. hepaticus was recognized as a new mouse pathogen and after a test method was established in our laboratory, it was confirmed that the cause of this abnormality was infection with this organism. According to results of tests

Suggested Citation:"Emerging Diseases in Mice and Rats." National Research Council. 2000. Microbial Status and Genetic Evaluation of Mice and Rats: Proceedings of the 1999 US/Japan Conference. Washington, DC: The National Academies Press. doi: 10.17226/9987.
×

on the cancer-bearing mice, the lesions were the same as those reported previously in immunodeficient mice, that is, focal liver necrosis and proliferative colitis. Curved bacilli were detected in the bile canaliculi surrounded by necrosis and in the crypts of the large intestine.

The specific DNA sequence of this organism was detected by polymerase chain reaction (PCR) in livers (20/21), cecal contents (21/21), and transplanted tumors (19/20) in these cancer-bearing mice. It was assumed that H. hepaticus bacteremia occurred in the infected immunodeficient mice similarly to the occurrence of Helicobacter bacteremia in AIDS patients. We first determined when H. hepaticus was introduced into the colony. PCR for H. hepaticus in cryopreserved tumors strongly suggested that the contamination occurred in 1990, as shown in Table 1. Based on the time of the tumor contamination and facility records, we suspect that this organism was brought into the facility by genetically engineered mice introduced from overseas.

We then investigated eliminating this organism from the contaminated tumor tissues. We passaged the tumor tissues collected from these infected animals directly into noncontaminated SCID mice under sterile conditions; however, after several weeks, we found that the organs and tumors of the mice were H. hepaticus DNA positive. In subsequent investigations, after cryopreserved samples of H. hepaticus DNA-positive tumor tissue were thawed and transplanted into SCID mice, we found that these mice were H. hepaticus free, and this organism had also been eliminated from the transplanted tumor tissues. From these results, it was assumed that the SCID mice had bacteremia due to H. hepaticus infection and the transplanted tissue was also contaminated. However, the bacterial count in each cryopreserved sample was low, the bacteria in the tissue were killed by the

TABLE 1 Helicobacter hepaticus Contamination in Cryopreserved Human Tumor Xenografts in Immunodeficient Mice

Year of Cryopreservation

No. Examined

No. Positive

1985

6

0

1986

18

0

1987

9

0

1988

5

0

1989

4

0

1990

12

1

1991

7

0

1992

20

1

1993

27

5

1994

11

1

1995

5

0

Suggested Citation:"Emerging Diseases in Mice and Rats." National Research Council. 2000. Microbial Status and Genetic Evaluation of Mice and Rats: Proceedings of the 1999 US/Japan Conference. Washington, DC: The National Academies Press. doi: 10.17226/9987.
×

freeze-thawing process, and no infectious bacteria remained even though the tissue was contaminated. After that, we confirmed that the process caused a decrease in the viable number of H. hepaticus to 10−1 or 10−2.

We found that in transplantation studies of tumors and organs using immunodeficient mice, H. hepaticus also caused persistent bacteremia in the same way that mouse hepatitis virus, Sendai virus, or Mycoplasma pulmonis infection causes viremia or bacteremia. As a result, the tumor and organ samples were contaminated. H. hepaticus should be considered one of the organisms that requires precautions in animal experimentation facilities. I would like to emphasize the importance of quarantine for biomaterials from immunodeficient animals.

ESTABLISHMENT OF TEST AGENTS

In the establishment of test agents for microbiologic monitoring, the issue is whether to establish individual test agents for each species (such as H. hepaticus or bilis) or to establish the tests for the genus as a whole (such as Helicobacter spp.). According to the FELASA recommendations, tests for Pasteurella spp. are specified for mice and rats, but tests for individual species (such as Pasteuella pneumotropica and multocida) are not specified. Several species of Helicobacter have been detected in mice, and some of these have not been confirmed as pathogenic. However, it appears that testing for Helicobacter spp. will be adopted in Europe and the United States. Therefore, I would like to present my thoughts concerning the selection of test agents with respect to international harmonization of quality control of laboratory animals.

I propose that organisms subject to testing in the microbiologic monitoring of laboratory animals be assigned a significance and be divided into the five main categories described in the Manual of Microbiologic Monitoring of Laboratory Animals, published as a result of prior US-Japan Meetings (USPHS/NIH 1994). These categories are A: zoonotic and human pathogens carried by animals; B: pathogens fatal to animals; C: pathogens not fatal but that can cause diseases in animals and affect their physiologic functions; D: opportunistic pathogens for animals; and E: indicators of the microbiologic status of an animal or colony.

At the ICLAS Monitoring Center, we believe that test agents should be selected for definite reasons. We therefore have established the following list for obtaining necessary information: whether the organism has been confirmed to be pathogenic, and effects on the experimental results are clear; convenience of testing (whether ordinary test methods are established and kits are available); prevalence or usefulness as an indicator of microbiologic control. An overly long list of test agents will result in an increase in costs over the whole range from production to the use of laboratory animals. Continuing qualitative improvement of laboratory animals cannot be expected with such an increase in costs. With respect to animal experimentation facilities in particular, the problem is how many users actually have facilities that can utilize such sophisticated animals.

Suggested Citation:"Emerging Diseases in Mice and Rats." National Research Council. 2000. Microbial Status and Genetic Evaluation of Mice and Rats: Proceedings of the 1999 US/Japan Conference. Washington, DC: The National Academies Press. doi: 10.17226/9987.
×

In the harmonization of quality tests, it is clear that selection of test agents is the most important factor. Therefore, test agents adopted for the genus should not be increased aimlessly, and caution is required. Overtesting is of benefit only to testing facilities and some large-scale producers; it does not necessarily improve the quality of laboratory animals and animal experimentation, which is our objective. In the selection of test agents, I believe that additional consultation is necessary among researchers performing animal experiments, animal breeders, and testing facilities.

REFERENCE

USPHS/NIH [US Public Health Service/National Institutes of Health] . 1994. Manual of Microbiologic Monitoring of Laboratory Animals. 2nd ed. (NIH Publication No. 94-2498). Washington, DC: GPO.

Suggested Citation:"Emerging Diseases in Mice and Rats." National Research Council. 2000. Microbial Status and Genetic Evaluation of Mice and Rats: Proceedings of the 1999 US/Japan Conference. Washington, DC: The National Academies Press. doi: 10.17226/9987.
×
Page 40
Suggested Citation:"Emerging Diseases in Mice and Rats." National Research Council. 2000. Microbial Status and Genetic Evaluation of Mice and Rats: Proceedings of the 1999 US/Japan Conference. Washington, DC: The National Academies Press. doi: 10.17226/9987.
×
Page 41
Suggested Citation:"Emerging Diseases in Mice and Rats." National Research Council. 2000. Microbial Status and Genetic Evaluation of Mice and Rats: Proceedings of the 1999 US/Japan Conference. Washington, DC: The National Academies Press. doi: 10.17226/9987.
×
Page 42
Suggested Citation:"Emerging Diseases in Mice and Rats." National Research Council. 2000. Microbial Status and Genetic Evaluation of Mice and Rats: Proceedings of the 1999 US/Japan Conference. Washington, DC: The National Academies Press. doi: 10.17226/9987.
×
Page 43
Next: Survey of Heliobacter Species in Laboratory Mice and Gerbils in Japan »
Microbial Status and Genetic Evaluation of Mice and Rats: Proceedings of the 1999 US/Japan Conference Get This Book
×
Buy Paperback | $50.00 Buy Ebook | $39.99
MyNAP members save 10% online.
Login or Register to save!
Download Free PDF

US/Japan meetings on laboratory animal science have been held virtually every year since 1980 under the US/Japan Cooperative Program on Science and Technology. Over the years these meetings have resulted in a number of important documents including the Manual of Microbiologic Monitoring of Laboratory Animals published in 1994 and the article Establishment and Preservation of Reference Inbred Strains of Rats for General Purposes. In addition to these publications, the meetings have been instrumental in increasing awareness of the need for microbiologic monitoring of laboratory rodents and the need for genetic definition and monitoring of mice and rats.

In cooperation with the Comparative Medicine section of NCRR/NIH, the ILAR Council and staff are pleased to become the host for this important annual meeting and look forward to participating in future meetings. The support and sponsorship of NCRR (P40 RR 11611) in the United States and the Central Institute for Experimental Animals in Japan are gratefully acknowledged. Bringing together the leading scientists in the field of laboratory animal care has resulted in increased understanding of American and Japanese approaches to laboratory animal science and should continue to strengthen efforts to harmonize approaches aimed at resolving common challenges in the use of animal models for biomedical research and testing. This effort to improve understanding and cooperation between Japan and the United States should also be useful in developing similar interaction with other regions of the world including Europe, Australia, and Southeast Asia.

  1. ×

    Welcome to OpenBook!

    You're looking at OpenBook, NAP.edu's online reading room since 1999. Based on feedback from you, our users, we've made some improvements that make it easier than ever to read thousands of publications on our website.

    Do you want to take a quick tour of the OpenBook's features?

    No Thanks Take a Tour »
  2. ×

    Show this book's table of contents, where you can jump to any chapter by name.

    « Back Next »
  3. ×

    ...or use these buttons to go back to the previous chapter or skip to the next one.

    « Back Next »
  4. ×

    Jump up to the previous page or down to the next one. Also, you can type in a page number and press Enter to go directly to that page in the book.

    « Back Next »
  5. ×

    Switch between the Original Pages, where you can read the report as it appeared in print, and Text Pages for the web version, where you can highlight and search the text.

    « Back Next »
  6. ×

    To search the entire text of this book, type in your search term here and press Enter.

    « Back Next »
  7. ×

    Share a link to this book page on your preferred social network or via email.

    « Back Next »
  8. ×

    View our suggested citation for this chapter.

    « Back Next »
  9. ×

    Ready to take your reading offline? Click here to buy this book in print or download it as a free PDF, if available.

    « Back Next »
Stay Connected!